SUZHOU, China, and ROCKVILLE, Md., Oct. 16, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has entered into a clinical collaboration with AstraZeneca Investment (China) Co., Ltd. (or "AstraZeneca"). The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca’s Bruton’s tyrosine kinase (BTK) inhibitor, CALQUENCE® (acalabrutinib), in treatment-naive patients with first-line chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

This global multi-center, randomized-controlled, open-label, pivotal Phase III confirmatory trial is designed evaluate the efficacy and safety of lisaftoclax combined with acalabrutinib versus immunochemotherapy in patients with treatment-naïve CLL/SLL.

This collaboration marks another step-forward in the joint clinical development of the lisaftoclax plus acalabrutinib combination by Ascentage Pharma and AstraZeneca. In June 2020, Ascentage Pharma entered into a clinical collaboration with Acerta Pharma, a research and development center of the AstraZeneca Group, to jointly conduct a global Phase II study designed to assess the safety, tolerability, and efficacy of lisaftoclax, Ascentage Pharma’s investigational Bcl-2 selective inhibitor, in combination with acalabrutinib, Acerta Pharma’s BTK inhibitor. In the study, lisaftoclax combined with acalabrutinib showed strong therapeutic potential, with an objective response rate (ORR) of 98% in patients with relapsed/refractory (R/R) CLL/SLL, an ORR of 100% in treatment-naïve patients with CLL/SLL, and an excellent safety profile that is on par with that of lisaftoclax monotherapy[1]. Those results were released as an Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting.

CLL/SLL is a hematologic malignancy caused by mature B-cell neoplasms. Primarily affecting older populations, CLL/SLL is among the most common leukemia subtypes in adults and accounts for a quarter of all leukemia cases in the Western World, with over 100,000 new diagnoses reported globally each year[2]. In China, CLL/SLL is occurring at a rapidly rising incidence rate, with a younger age of onset and higher aggressiveness[3], thus posing a serious threat to public health in the country. Advancements in basic research and targeted therapies have brought meaningful survival benefit to patients with CLL/SLL. However, CLL/SLL still presents major clinical challenges and urgent medical needs for new treatment options that can offer both efficacy and safety.

Lisaftoclax is a novel, orally administered small-molecule Bcl-2 selective inhibitor being developed by Ascentage Pharma to treat malignancies by selectively blocking the antiapoptotic protein Bcl-2 and hence restoring the normal apoptosis process in cancer cells. With strong global best-in-class potential, lisaftoclax is the first Bcl-2 inhibitor in China and the second anywhere globally that has demonstrated compelling clinical activity and entered a pivotal registrational study. At present, lisaftoclax is being evaluated in multiple clinical studies across the world and more than 300 patients with CLL/SLL have already been treated with the drug. Interim results suggest that lisaftoclax, both as a monotherapy and in combination regimens, offers potent efficacy in patients with CLL/SLL and has the potential as a safer, more efficacious and more patient-friendly treatment option. It is also worth noting that in August 2023, lisaftoclax was cleared by the US Food and Drug Administration (FDA) to enter a global registrational Phase III study designed to assess the efficacy and safety of lisaftoclax combined with a BTK inhibitor in patients with CLL/SLL who have received prior therapies.

Acalabrutinib, a new generation highly selective BTK inhibitor that can specifically inhibit the BTK pathway, is a globally-adopted standard of care treatment for patients with CLL. In 2017, acalabrutinib was approved through the Priority Review process by the US Food and Drug Administration (FDA) for the second-line treatment of patients with mantle cell lymphoma (MCL), and subsequently in 2019, the drug was approved for the additional indication of adult patients with CLL/SLL. Meanwhile, acalabrutinib has been approved in more than 50 countries/regions, such as European Union and Japan until now. In China this year, acalabrutinib was sequentially approved for two indications that include patients with MCL who have received at least one prior therapy; and adult patients with CLL/SLL who have received at least one prior therapy.

Dr. Yifan Zhai, Chief Medical Officer of Ascentage Pharma, said, "Combining Bcl-2 inhibitors and BTK inhibitors as a therapeutic approach has long attracted interest from both the research community and the industry. The Bcl-2 inhibitor lisaftoclax is a key drug candidate in Ascentage Pharma’s apoptosis-targeted pipeline. Results from the global Phase II study of lisaftoclax combined with acalabrutinib show that the combination regimen holds the promise as a patient-centric treatment strategy with enormous therapeutic potential. The clinical management of CLL/SLL overseas has already entered an era that is free of chemotherapies, and patients in China also desperately need a safer and more effective Bcl-2 inhibitor that can be combined with BTK inhibitors. Fulfilling our mission of addressing unmet clinical needs in China and around the world, we will work closely with AstraZeneca to actively advance this clinical development program of lisaftoclax and try to bring the drug to market as soon as possible for the benefit of more patients."

Ms. Haiying Yang, Vice President and Head of Medical Affairs at AstraZeneca China, commented, "Phase III results from the ASCENT, ELEVATE-TN, and ELEVATE-RR trials have solidified AstraZeneca’s position in the hematology field, while acalabrutinib-based combination regimens have been widely adopted as standard of care treatments. BTK inhibitors offer survival benefits to patients with lymphoma. However, there remains substantial clinical challenges in this therapeutic area and patients are in desperate need for new therapies that are both safe and efficacious, particularly fixed duration therapies. We are confident that acalabrutinib-based combinations can bring more effective and precision-targeting therapies to patients with hematologic malignancies in China as we take further steps in rendering hematologic malignancies into manageable chronic conditions. Through these innovative partnerships with local Chinese companies, we aspire to expand to more therapeutic areas and bring clinical benefit to a broader population of cancer patients in China."

References

[1] Davids M, Chanan-Khan A, Mudenda B, et al. Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study. Blood (2022) 140 (Supplement 1): 2326–2328.

[2] Yao, Y., Lin, X., Li, F. et al. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019. BioMed Eng OnLine 21, 4 (2022). https://doi.org/10.1186/s12938-021-00973-6

[3] 刘澎. 复旦大学附属中山医院慢性淋巴细胞白细胞/小淋巴细胞淋巴瘤诊疗规范（v1.2018）[J].中国临床医学, 2018, 25(1).

About Ascentage Pharma

Ascentage Pharma (6855.HK) is a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B, and age-related diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code 6855.HK.

Ascentage Pharma focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company has built a pipeline of 9 clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors (TKIs). Ascentage Pharma is also the only company in the world with active clinical programs targeting all three known classes of key apoptosis regulators. The company is conducting more than 40 clinical trials in the US, Australia, Europe, and China. Ascentage Pharma has been designated for multiple Major National R&D Projects, including five Major New Drug Projects, one New Drug Incubator status, four Innovative Drug Programs, and one Major Project for the Prevention and Treatment of Infectious Diseases.

Olverembatinib, the company’s core drug candidate developed for the treatment of drug-resistant chronic myeloid leukemia (CML) and the company’s first approved product, has been granted Priority Review Designations and Breakthrough Therapy Designations by the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA). To date, the drug had been included into the China 2022 National Reimbursement Drug List (NRDL). Furthermore, olverembatinib has been granted an Orphan Drug Designation (ODD) and a Fast Track Designation (FTD) by the US FDA, and an Orphan Designation by the EMA of the EU. To date, Ascentage Pharma has obtained a total of 16 ODDs, 2 FTDs, and 2 Rare Pediatric Disease (RPD) Designations from the US FDA and 1 Orphan Designation from the EMA of the EU for 4 of the company’s investigational drug candidates.

Leveraging its robust R&D capabilities, Ascentage Pharma has built a portfolio of global intellectual property rights and entered into global partnerships with numerous renowned biotechnology and pharmaceutical companies and research institutes such as UNITY Biotechnology, MD Anderson Cancer Center, Mayo Clinic, Dana-Farber Cancer Institute, MSD, and AstraZeneca. The company has built a talented team with global experience in the discovery and development of innovative drugs and is setting up its world-class commercial manufacturing and Sales & Marketing teams. One pivotal aim of Ascentage Pharma is to continuously strengthen its R&D capabilities and accelerate its clinical development programs, in order to fulfil its mission of addressing unmet clinical needs in China and around the world for the benefit of more patients.

Forward-Looking Statements

The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, Ascentage Pharma undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development.

Source : Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

GUANGZHOU, China, Oct. 16, 2023 /PRNewswire/ — Pantum, a leading provider of printing solutions specializing in the development, manufacturing, and distribution of laser printers and toner cartridges, is set to unveil its latest product offerings and cutting-edge innovations at its debut appearance in the 134th China Import and Export Fair(also known as the Canton Fair). The event commenced on October 15, 2023, in Guangzhou, China.

At present, Pantum has mastered complete technologies and products at all levels to fulfil various users’ needs. Pantum has a full range of products from entry level to high level, single function to multi-function, monochrome to color, a4 to a3, laser printers to extended products. At this Canton Fair, users will see Pantum’s changes in new products. 

As a brand making its first appearance at the Canton Fair, Pantum will feature two new highly efficient product series designed for simplicity and ease of use: the CM2100 series, a 20ppm A4 color laser printer series, and the BM2300 series, a 22ppm A4 monochrome laser printer series. Pantum is at booth B32-34 of Hall 6.1 at the Canton Fair Complex.

Pantum at the Canton Fair 1

Leon Zhang, Deputy Marketing Manager of Pantum, expressed, "The five-day Canton Fair as the most important exhibition in China, and the largest import and export trade show, has huge influence on a global scale. Participating in this influential international trade show provides Pantum with the opportunity not only to introduce our flagship products and brand strength to global buyers, but also is a key step as we accelerate our global market development. We hope to collaborate with partners both domestically and internationally to achieve mutual success."

The CM2100 series offers an unparalleled printing experience with outstanding color performance, boasting a printing speed of up to 20 pages per minute (ppm) for A4-sized paper. It also features the merge scan capability with ADF and Flatbed, enabling users to scan multi-page documents and compile them into a single document to improve working efficiency. The series is also compatible with ChromeOS, the Wi-Fi model supporting Bluetooth network configuration, and the ADF (automatic document feeder) model equipped with a 3.5-inch touchscreen.

Pantum at the Canton Fair 2

The BM2300 series, designed for ease of operation, offers driver-free installation for Win8.1/Win10/Win11 systems. The Wi-Fi model provides Bluetooth network configuration and supports 2.4G/5G dual-band Wi-Fi, along with the Pantum PiPMe Management Software.

In the meantime, Pantum is also highlighting two new monochrome high-speed laser printers at the Canton Fair, tailored for offices with exceptional efficiency and effortless operation. The BM5200 series sets new productivity standards with a rapid printing speed of up to 42ppm for A4 papers, Single-pass Duplex Scanning (DADF), FPOT of less than 5.9 seconds, and a maximum paper input capacity of up to 1,410 pages. The BM5200ADW model supports 2.4G/5G dual-band Wi-Fi, Bluetooth configuration, and the Pantum PiPMe Management Software.

The CM270ADN A3 color laser printer has a printing speed of 25ppm and supports auto duplex printing, copying, and scanning capabilities. It supports secure and confidential printing with direct scan or print from USB disk feature. The 7-inch color panel also enhances interaction to improve user experience.

Pantum’s showcase at the Canton Fair also includes a variety of color and monochrome laser printers for A3 and A4 with printing speeds ranging from 20 to 42ppm, as well as label printers and scanners.

Pantum at the Canton Fair 3

Pantum is always committed to introducing exciting new products catering to the needs of both enterprises and individual users. The company welcomes all guests to visit Pantum’s booth at the Canton Fair, and witness firsthand the cutting-edge technology and exceptional performance of its printers, label printers, and scanners. Stay tuned for more exciting developments from Pantum.

About Pantum

Founded in 2010, Pantum is a printer manufacturer with comprehensive portfolio covering printers, printing materials, and printing solutions and services. Since 2011, Pantum began its overseas expansion with a current global footprint of more than 110 countries. With its patented technology, Pantum is committed to meeting evolving printing needs by offering cost-effective, user-friendly, and energy-efficient products, along with reliable printing solutions. Today, Pantum continues to deliver enhanced value to its customers through its budget-friendly products and premium services.

For more information, please visit our website, Facebook, Instagram, and YouTube.

Source : Pantum Showcases Latest Product and Technology Innovation at 134th Canton Fair

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Pairs of Watches for Partners Evoke the Festive Look of Winter Illuminations

Also Worn by Five-Member South Korean Girl Group ITZY

TOKYO, Oct. 16, 2023 /PRNewswire/ — Casio Computer Co., Ltd. announced today the release of the latest addition to the G-SHOCK brand of shock-resistant watches. Seasonal Collection 2023 presents five new limited-edition models for the winter season, which can be worn in pairs by partners for a coordinated look. Featuring shining metallic-colored dials, the GM-2100WS, GM-S2100WS, GA-2100WS, GMA-S2100WS, and GA-110WS watches evoke the sparkling beauty of festive winter illuminations.

The five new shock-resistant timepieces making up this season’s lineup — the GM-2100WS, GM-S2100WS, GA-2100WS, GMA-S2100WS, and GA-110WS — feature dials treated with brilliant metallic vapor deposition in a charming array of hues inspired by the gorgeous look of festive decorations and illuminations brightening the streets of winter.

The diverse lineup includes a range of sizes, designs, and color schemes, offering the enjoyment of coordinating a paired fashion look with a romantic partner, friend, or family member. With colorful dials set off against both metal and resin bezels, the watch design features a base tone of white and forms modeled after the GA-2100, with its iconic octagonal bezel, and the GA-110, with its distinctive dimensional dial.

Featuring metal bezels and differing sizes, the GM-2100WS and GM-S2100WS present a cool, stylish look with their respective navy and pink dial colors.

The GA-2100WS, GMA-S2100WS, and GA-110WS feature resin bezels and showcase dials in vivid hues of blue, orange, or purple that shine with striking brilliance.

As a special design feature for a lineup of watches meant for pairing, an image of string looped and tied into a heart shape is engraved on the case back of each watch to express bonds or ties of connection with people near and dear.

A new promotional image features the five members of South Korean girl group ITZY proudly wearing all five models of the G-SHOCK Seasonal Collection 2023.

Source : Casio to Release G-SHOCK Watches with Shining Metallic-Colored Dials

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SINGAPORE, Oct. 16, 2023 /PRNewswire/ — Sozo Aesthetic Clinic is launching an updated acne scar treatment program for modern busy professionals in Singapore. Dr Justin Boey, Medical Director, explains more about acne scars treatments in Singapore. This program is a medically proven combination of procedures that removes acne scars permanently and successfully. Acne and acne scars is a problem for busy working professionals as it can be embarrassing.

Acne scars are depressions on the skin that can be permanent if not treated immediately and properly. While many ignore their acne scars, some people see it as a bothersome condition that contributes to reducing their self-esteem, especially if their jobs require them to look appealing at all times.

There are a lot of do-it-yourself acne scars treatments searchable on the internet – but not all are guaranteed safe and effective. Acne scars treatments vary on different individual’s skin. One remedy is sufficient for specific skin types, while to others, it provides more breakouts, which leads to more stubborn acne scars.

This Raffles Place clinic shared that one acne scar treatment is not enough to fully cure acne scars. "Acne Scars are challenging to improve, and sticking with one treatment is often inadequate. A lot of patients are unsatisfied with their acne scars treatment results."

"We recommend different methods based on our patient’s skin type and the extent of the scarring."

Sozo Aesthetic Clinic in Singapore has numerous acne scars treatments that are medically proven for all people struggling with it. Their upgraded acne scar treatment protocol for the year 2023 will target deep and stubborn facial acne scars using three proven therapies to treat the root cause of acne scars.

Firstly, the Subcision and Dermal Filler are either performed to make the appearance of scars shallower. The next step is Fractional RF Microneedling (INFINI), which is for deep skin remodelling. Lastly, the Fractional CO2 or Fractional Pico Laser is for superficial skin resurfacing that delivers tiny microthermal zones in the target areas.

"To perfect the skin even more, light touches of TCA cross chemical peel can be done to minimize those pores." Dr Justin Boey, Medical Director of Sozo Aesthetic Clinic, suggested.

About Sozo Aesthetic Clinic

Sozo Aesthetic Clinic is an aesthetic medical clinic in Singapore that serves patients from all over South-East Asia. They offer a comprehensive collection of Acne Scar treatments. Their services are featured in a lot of famous media outlets in Singapore.

Find them at
1 Raffles Place #05-12/13, Singapore 048616
Phone: 69351811
Website: https://sozoclinic.sg
Media contact: [email protected] 

Source : Sozo Aesthetic Clinic, Raffles Place in Singapore, Introduces Updated Scars Treatment Protocol

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

HONG KONG, Oct. 16, 2023 /PRNewswire/ — Heidrick & Struggles (Nasdaq: HSII), a premier provider of global leadership advisory and on-demand talent solutions, added one partner to its Executive Search business in Asia Pacific in September 2023.

Puneet Malhotra joined Heidrick & Struggles as a partner in the New Delhi office. A member of the Global Technology & Services practice, Puneet is a trusted advisor to global clients on executive-level talent solutions and succession planning. For nearly 20 years, he has worked across a range of C-suite mandates for technology, software, and professional services firms.

"Technology and services organizations must remain prepared and flexible as they scale their operations to meet the demands of a growing global market," said Stephen McAlinden, Regional Leader, Asia Pacific and the Middle East. "With a wealth of experience in succession planning and executive-level talent in the tech sector, Puneet brings a critical perspective to our clients on the leading edge of innovation and business transformation."

About Heidrick & Struggles
Heidrick & Struggles (Nasdaq: HSII) is a premier provider of global leadership advisory and on-demand talent solutions, serving the senior-level talent and consulting needs of the world’s top organizations. In our role as trusted leadership advisors, we partner with our clients to develop future-ready leaders and organizations, bringing together our services and offerings in executive search, diversity and inclusion, leadership assessment and development, organization and team acceleration, culture shaping and on-demand, independent talent solutions. Heidrick & Struggles pioneered the profession of executive search more than 70 years ago. Today, the firm provides integrated talent and human capital solutions to help our clients change the world, one leadership team at a time.® www.heidrick.com

Heidrick & Struggles Media Contact:
Lillian Lee
+852 2103 9389
[email protected]

Source : Heidrick & Struggles Adds Executive Search Partner in Asia Pacific

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Contributing towards financial inclusion and growth of digital economy through digital initiatives and partnerships.

MANILA, Philippines, Oct. 16, 2023 /PRNewswire/ — Collabera Digital, a leading provider of Digital Engineering services, is the partner of choice for the latest digital banking platform by UNO Digital Bank, to increase and expand their user base through developing and integrating a mini application in GCash, the largest Fintech and Lifestyle SuperApp in the Philippines extending across millions of engaged GCash users.

UNO Digital Bank is Southeast Asia’s first full-spectrum digital bank that aims to provide online banking solutions hinged on the latest technology. Their mission is to provide a single trusted interface to manage one’s entire financial life cycle journey with speed and ease. The company was one of the first Fintech companies to receive an outright Digital Banking License from the Bangko Sentral ng Pilipinas. UNO Digital Bank continues to partner with trusted and effective members of the banking and financial services industry to help elevate the banking experience to one that is more accessible, reliable, and secure.

GCash, owned by the Philippines’ first and only double unicorn, Mynt, is the leading finance SuperApp in the Philippines. It provides convenient and secure financial services to its users and has been a major enabler of the country’s financial inclusion agenda. The app offers various services like sending money, bills payment, e-commerce, savings, investments, insurance, lending, and more. Furthermore, GCash is committed to sustainability, promoting a green digital lifestyle, and contributing to a greener future. It also prioritizes the safety of its users, strengthening account protection and empowering customers with education as well as investments in trust and security innovations.

The joint efforts between UNO Digital Bank, GCash, and Collabera Digital have made digital financial services easily accessible to individuals, regardless of their socio-economic status or location in the Philippines. The collaboration has also contributed to the growth of the digital economy by revolutionizing the way people conduct business through mobile banking and digital wallets.

Collabera Digital was instrumental in helping UNO Digital Bank and GCash, with the right tech strategy that addressed AML (Anti-Money Laundering) and KYC (Know Your Customer) systems and building a robust, integrated API platform. This strategic partnership enabled business agility and faster time to market, resulting in a seamless customer experience, increase in user base, faster account opening, and convenient cash-in and cash-out options for end customers.

"Our partnership with GCash is significant in scaling and increasing our customer reach. As a greenfield bank, built independently of a larger traditional institution, we have to be innovative in identifying opportunities to grow and expand. GCash, with their 80M+ users and active thrust towards financial inclusion, is a great partner leading to a win-win proposition for both the entities", said Manish Bhai, Founder and CEO of UNO Digital Bank.

According to Manan Mehta, Senior Vice President and Country Head of Collabera Digital in the Philippines, the success of this engagement is a result of the collaborative efforts of all stakeholders. Manan said, "By leveraging our deep understanding of GCash and UNO Digital Bank’s tech stack and their value proposition, our team brought in proven digital engineering methodologies, by successfully integrating UNO Digital Bank into GCash’s SuperApp. We are proud of our team for surpassing the expectations of both our customers in terms of timelines and quality of delivery." Manan also expressed enthusiasm about the continuation of Collabera Digital’s game-changing partnership with UNO Digital Bank and GCash which promises to drive financial inclusion in the Philippines.

The significance of this partnership lies in the collaboration of diverse stakeholders, including financial institutions, technology companies, and the society at large, all of whom play vital roles in promoting financial inclusion and advancing the digital economy in the country.

About Collabera Digital

Collabera Digital is a new age digital engineering company delivering unique experiences, actionable insights, and intelligent products & platforms at the intersection of talent & technology. We are at the forefront of innovation, blending human creativity with smart technologies to drive transformative solutions. Our client-first and highly collaborative approach enables organizations to accelerate their digital journeys with efficiency and velocity at scale.

Since our inception in 2010, Collabera Digital has soared to unparalleled heights. With a global presence spanning 11 countries throughout APAC and Europe, our network of over 25 offices serves as the epicenter of digital innovation. We proudly cater to a prestigious clientele, counting Fortune 500 companies amongst our 300+ esteemed clients.

For more information, visit https://collaberadigital.com.

About UNO Digital Bank

UNO Digital Bank is a full-spectrum credit-led digital bank licensed under the Digital Banking License framework promulgated by the Bangko Sentral ng Pilipinas (BSP) in the Philippines. With UNO Digital Bank, Filipinos can use one trusted app to save, borrow, transact, invest, and protect their money; to manage their finances with speed and ease.

For more information about UNO Digital Bank, please visit https://uno.bank.

Source : UNO Digital Bank partners with Collabera Digital to enable seamless integration with GCash

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

LOTTE rent-a-car, No.1 in market share for rental cars in Korea… Equipped with professional manpower for foreign customers "What about CDW coverage?" Introducing the most frequently asked questions from foreign tourists Recommended tourist destinations in the Seoul metropolitan area, Busan, and Jeju Island for foreign tourists visiting Korea

SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ — Korea is a popular travel destination visited by numerous foreigners every year. They visit Korea to enjoy its diverse culture, historical heritage, and beautiful scenery. According to the Korea Tourism Organization, the number of foreign tourists who visited Korea in July was 1,032,188, exceeding 1 million per month for the first time since COVID-19.

Foreign tourists’ interest in Korea has increased significantly. LOTTE rent-a-car, Korea’s No. 1 rental car brand, introduces in detail the entire process of renting a car when traveling in Korea. It also contains the most frequently asked questions by foreign tourists. We recommend the Seoul metropolitan area, Busan, and Jeju Island, which are the most preferred travel destinations for foreign tourists and where you can travel by rental car.

Korea’s No.1 rental car brand, LOTTE rent-a-car
LOTTE rent-a-car is the company with the largest share of the rental car market in Korea. As the use of short-term rental cars by foreigners visiting Korea is increasing, we have professional response staff and rental manuals for foreign customers. We operate a 24-hour customer center so we can respond to incidents at any time.

The sales network is spread across the country, making it convenient to use. Lotte Rent-a-Car can be used at 5 airports, including Incheon, Gimpo, and Gimhae Airport, and 17 train stations, including Seoul Station, Busan Station, and Gangneung Station.

What are the most common questions asked by foreign tourists renting a car in Korea?
So, what are foreign tourists most curious about when visiting Korea and traveling by rental car? We divided it into rental car reservation, payment, and use and asked LOTTE rent-a-car Seoul Station branch and Incheon International Airport Sales Office, which has a high proportion of foreign customers.

[Rental car reservation]

1. What is required to rent a car?

A driver’s license and identification (passport or residence card) are required. An ‘International Driving Permit(IDP)’, which is a license that allows you to drive in a country other than the country where you own the driver’s license, is also recognized. For IDP holders, a ‘passport’ or ‘passport information certificate’ to prove the date of entry is required. You must bring the original IDP when picking up the vehicle. Copies, PDFs, or photos of the IDP cannot be used. The vehicles that can be used vary depending on the IDP level. For grade B, you are allowed to drive up to a nine-seater vehicle and grade D, you are allowed to drive up to a twelve-seater vehicle.

2. Is the Taiwanese International Driving Permit accepted?

From February 2022, Taiwan International Driving Permit is accepted.

3. Is the European Union International Driving Permit accepted?

European Union International Driving Permit is not accepted.

[Payment and use of rental car]

1. When renting a car, is it possible to pay in cash or with Apple Pay?

It is not possible. Payment can only be made by credit or debit card. If you don’t have a card, you can purchase a Wow Pass card near Seoul Station.

2. How do I use the navigation?

English GPS is installed. You can search by address, phone number, or postcode. If you want to save it, you can save the destination to GPS when searching for it.

3. In the case of an SUV or VAN, how many people can ride and how many suitcases can it carry?

Compact and standard vehicles can generally seat 4 people and carry 2 large and 1 small piece of luggage. The SUV can seat 5 people and carry 3 large pieces of luggage and 1 small piece of luggage. A van can typically seat 6 people and carry 3 large pieces of luggage and 1 small piece of luggage. As each vehicle is different, please refer to the car class on the LOTTE rent-a-car website.

4. How do I pay highway tolls?

Purchase a Hi-Pass card and pay. You can purchase it when renting a car at a LOTTE rent-a-car branch. It can also be purchased at convenience stores and highway rest areas. For cards purchased at a branch, 30,000 won is charged, and the price of the charged card is 35,000 won. There will be no refund if you return the card. You can pay in cash at the tollgate, but there are often unmanned tollgates, so you need to check. Tollgate toll fees can be found through GPS.

5. Are there any special benefits available to foreign customers?

We are conducting a free charging promotion for all foreign customers who rent electric vehicles at LOTTE rent-a-car branches at Jeju Auto House, Seoul Station, Incheon International Airport, Busan Station, Haeundae, and Gimhae Airport. A charging card is provided to foreign customers who rent an electric vehicle.

[CDW(Car Damage Waiver)]

1. What is the coverage of the CDW(Car Damage Waiver)?

CDW is a system that protects customers against car accidents caused by their own mistakes. For the convenience of foreign customers, they must sign up with complete exemption. If you sign up for CDW, you will be exempt from liability for vehicle damage, but there are exceptions, such as tire problems, vehicle replacement, and interior damage. All LOTTE rent-a-car vehicles are in full coverage insurance, so in the event of a traffic accident, third party liability can be insured up to unlimited coverage, property damage up to 20 million won, and personal injury up to 15 million won.

2. How much is the compensation fee for inoperable vehicle?

If an accident occurs, you will have to pay for business losses during the car repair period. You are responsible for 50% of the standard rental fare corresponding to the period required for the repair of inoperable vehicle in case of accident. The contract will be automatically terminated when the vehicle is inoperable, and we do not provide substitution vehicle.

Recommended travel destination_ The heart of Korea, the metropolitan area
Seoul, the capital of Korea, is the most popular tourist destination in Korea for foreigners. According to the foreign tourist survey report conducted by the Korea Culture and Tourism Institute, the regions visited by foreign tourists visiting Korea in 2022 were Seoul (81.7%), Busan (22.8%), Gyeonggi (15.3%), and Jeju (13%). (Multiple responses).

Recommended places in Seoul and other metropolitan areas are LOTTE WORLD TOWER and Nami Island.

LOTTE WORLD TOWER is the world’s 5th tallest skyscraper, with a total of 123 floors and a height of 555 meters. There is the five-star hotel ‘Signiel Seoul’, ‘Seoul Sky’, an observatory where you can see the splendid night view of Seoul, ‘Avenuel’, the largest luxury department store in Korea, and ‘LOTTE DUTY FREE’, which has the largest area among duty free shops in Korea. It is a famous spot where you can enjoy sightseeing. Among these, the most popular attraction is Seoul Sky, which offers a 360-degree view of the city of Seoul. LOTTE rent-a-car has prepared various benefits for the VISIT KOREA YEAR 2023-2024. When the customer rents any vehicle for 3 days or more (72 hours or more) or a premium vehicle(Genesis GV70, G80, GV80, G90) for 1 day or more (24 hours or more) via LOTTE rent-a-car at Incheon International Airport, Gimpo Airport branch, or branch offices in Seoul, two complimentary tickets to The Seoul Sky Observatory are provided.

Nami Island is a travel destination where culture, art and natural ecology are alive. As it became known as a filming location for the drama "Winter Sonata," which aired in 2002, the number of domestic tourists as well as travelers from Asian countries and regions such as Japan, Taiwan, Mainland China, and Southeast Asia increased rapidly. As foreign tourists account for half of all tourists, the service for foreigners is well provided." Information services are provided in 10 languages, including English, Chinese, Japanese, Thai, and Vietnamese.

Recommended travel destination_ Busan, the second largest city in Korea
Along with Seoul, Busan is also a destination visited by many foreign tourists. Busan is Korea’s representative maritime city and the second largest city in Korea. Haeundae Beach and Haedong Yonggungsa are also worth visiting.

Haeundae Beach is known as the pinnacle of Busan’s beaches. It is a place where you can feel the dynamic atmosphere of Busan more than any other place. It is well-equipped with recreational and auxiliary facilities centered around a 1.5㎞ long white sandy beach, so many people visit regardless of nationality and age. The view of Marine City at night from The Bay 101 is also a course not to be missed. It is recommended to park in a public parking lot near the beach and visit the food stall village and traditional market.

Haedong Yonggungsa is a temple representing Busan and a coastal temple representing Korea. Most temples are located in the mountains, but Haedong Yonggungsa Temple is built on a cliff on the coast of Gijang, offering an outstanding view. This place, with its clear East Sea and beautiful scenery, has become a must-visit destination for those visiting Busan. On the bridge, many visitors make wishes by throwing coins. There is a saying that if you pray earnestly, your wish will come true.

Recommended travel destination_ Jeju Island, a world-famous volcanic island
Jeju Island is a world-famous volcanic island. There are many tourist attractions that display Jeju Island’s topographical characteristics, such as Oreum, a parasitic volcano created by volcanic activity, and Lava Tube, a cave formed beneath the surface of hardened lava. Among them, Seongsan Ilchulbong and Halla Mountain are representative tourist destinations in Jeju.

Seongsan Ilchulbong is shaped like a towering fortress amidst the blue sea. When you reach the top, you can see a huge bowl-shaped crater at a glance. It was named ‘Seongsan’ because it looks like a huge castle, and ‘Ilchulbong’ because the view of the sun rising is spectacular.

Halla Mountain, the highest mountain in Korea, is also popular with foreign tourists. At the top of the mountain is a crater lake, a lake filled with water caused by a blocked volcanic vent. Since the temperature varies greatly depending on the height of Halla Mountain, various plants are distributed there.

Choi Jin-hwan, CEO of LOTTE rental, stated, "LOTTE rental is striving to create an environment where foreign customers can use a variety of services more conveniently. We will provide convenient rental car services so that foreign tourists visiting Korea can experience the charm of Korea by using LOTTE rent-a-car."  

About LOTTE rental

LOTTE rental, the only comprehensive rental company in Korea, provides better value with various business portfolios, including auto mobility services that encompass car life, business solution services that support more effi­cient businesses.

LOTTE rent-a-car is creating an innovative car life as the No.1 car rental brand. Greencar, Korea’s ‑first car-sharing brand, is drawing a better mobility service.

LOTTE rental is moving forward as a mobility leader that connects customers’ precious lives.

For more information about LOTTE rental, please visit: https://www.lotterental.com/

Source : LOTTE rent-a-car guides foreign tourists on how to use Korean rental cars smartly

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ — CrossAngle, the operator of the crypto data intelligence platform Xangle, announced today the release of the "The Giant of Southeast Asia, Indonesia Web3 Market Report." This report is a collaborative effort with Asian Web3 market consulting firm Tiger Research.

CrossAngle and Tiger Research partnered in April and have been actively working together to create and share Web3 industry-related content.

The joint report aims to offer a comprehensive understanding of the unique and intricate structure of Indonesia’s Web3 market. Key topics covered in the report encompass an overview of the Indonesian Web3 market, the Indonesian Web3 infrastructure ecosystem, cryptocurrency exchanges in Indonesia, and the Indonesian NFT market.

As per the report, Indonesia boasts the most vibrant cryptocurrency exchange market compared to other sectors. Presently, there are over 30 operational exchanges, catering to approximately 10 million crypto customers, equivalent to roughly 4% of the Indonesian population. This number aligns closely with the count of investors participating in the Indonesian stock exchange.

Nonetheless, the Indonesian NFT market is currently experiencing an unprecedented low due to the recent market downturn, and local marketplaces have struggled to gain substantial traction. Additionally, the developer ecosystem remains relatively modest, with numerous unicorns outsourcing development work overseas.

However, the research team behind the joint report holds the belief that Indonesia’s Web3 market possesses significant untapped potential. With the world’s fourth-largest population, a sprawling market, a youthful and engaged demographic with a median age of 30, and a backdrop of political stability coupled with Web3-friendly policies, Indonesia presents a promising landscape. In recent years, the Indonesian government has displayed a favorable stance toward the Web3 industry. They have introduced multiple incentives to foster its growth and have established a dedicated committee for the blockchain sector under the Indonesia Financial Services Authority.

The Indonesia Web3 market analysis report results from a week-long research expedition to Indonesia. During this time, the research team conducted in-person interviews with local experts and entrepreneurs. Beyond presenting precise data, the report incorporates real-life perspectives gathered during these on-the-ground interactions, enhancing its practical value.

The complete report is available for reference on both Xangle’s website and Tiger Research’s website.

Source : Xangle and Tiger Research Co-Publish "The Giant of Southeast Asia, Indonesia Web3 Market Report"

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network